CLTB

CLTB encodes clathrin light chain B (LCb), a regulatory subunit of the clathrin triskelion that, together with its close relative LCA, binds the proximal segment of a clathrin heavy chain leg through a central set of ten heptad-repeat alpha-helical coiled-coil elements, with the amino- and carboxyl-terminal segments positioned to mediate interactions with other proteins (PMID:3563513). LCb is incorporated into triskelions and coated vesicles in proportion to its cellular expression level rather than by preferential selection, and is distinguished from LCA by site-specific regulation: it is preferentially phosphorylated at serines 11 and 13 by a coated vesicle-associated casein kinase II (PMID:3128543, PMID:2211818). LCb is expressed at relatively higher levels than LCA in cells maintaining a regulated secretory pathway and has a longer metabolic half-life (~45 h, comparable to clathrin heavy chain), indicating it is turned over coordinately with the assembled coat (PMID:2211818). Tissue-specific LCb isoforms, including a neuron-specific insert, are generated by alternative splicing of a discrete exon, and the human CLTB gene maps to chromosome 4q2-q3 (PMID:7713494). Beyond these properties, the functional consequence of LCb phosphorylation and its specialized role in regulated secretion have not been mechanistically resolved in the available corpus.

1. 1987 Medium

   Establishing how clathrin light chains are organized at the sequence level answered how LCb associates with the triskelion and predicted which regions mediate heavy chain versus accessory interactions.

   Evidence cDNA cloning and structural sequence analysis of rat LCA and LCB heptad-repeat coiled-coil motifs

   PMID:3563513

   Open questions at the time

   • Heavy chain binding was inferred from sequence/structural modeling, not directly reconstituted
   • Identity of the proteins binding the terminal segments was not established
   • Functional distinction between LCA and LCB not addressed
2. 1988 High

   Identifying serines 11 and 13 as preferential phosphorylation sites distinguished LCb biochemically from LCA and tied it to a coat-associated kinase activity.

   Evidence In vitro [32P]ATP phosphorylation within coated vesicles, chymotryptic peptide mapping, and monoclonal antibody inhibition

   PMID:3128543

   Open questions at the time

   • Functional consequence of serine 11/13 phosphorylation on coat assembly or disassembly not determined
   • Physiological trigger and regulation of the casein kinase II activity unknown
3. 1990 High

   Quantifying LCb expression, incorporation, and turnover tested whether LCb has a specialized role and showed it correlates with the regulated secretory pathway while being assembled stoichiometrically with the coat.

   Evidence Comparative LCa/LCb expression ratios across tissues, pulse-chase half-life measurement, and coated vesicle fractionation

   PMID:2211818

   Open questions at the time

   • Correlation with regulated secretion does not establish a causal mechanistic role
   • Why LCb turnover matches heavy chain while LCA turns over independently is unexplained
4. 1994 Medium

   Defining the human CLTB gene structure explained how tissue-specific LCb variants arise and placed the locus in the genome.

   Evidence Chromosomal mapping and genomic clone characterization identifying a discrete neuron-specific exon

   PMID:7713494

   Open questions at the time

   • Functional difference between neuronal and non-neuronal LCb isoforms not characterized
   • Regulation of the alternative splicing event not addressed

• The downstream function of LCb phosphorylation and its mechanistic contribution to regulated secretion versus constitutive endocytosis remain open.
• No reconstituted assay linking serine 11/13 phosphorylation to coat dynamics
• No defined accessory protein partners for the LCb terminal segments
• No structural model of LCb within the assembled coat in the corpus